Trial intelligence / Profile preview

PreYIAL: Azithromycin in Labour

NCT03925480Phase 3Completed

Sponsor
Murdoch Children's Research Institute
Start
Jul 2019
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in skin and soft tissue infection (SSTI) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Cumulative incidence of skin and soft tissue infection at 3 months. Started Jul 2019; status: completed.

02

Drugs

azithromycin
03

Conditions

skin and soft tissue infection (SSTI)

Beyond the preview

Go deeper on NCT03925480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03925480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call